4月13日——Allogene Therapeutics Inc宣布计划启动一项规模达1.75亿美元的普通股公开发行。该公司表示,此次发行所得净资金将用于企业一般运营需求,包括临床试验推进及研发项目投入。
4月13日——Allogene Therapeutics Inc宣布计划启动一项规模达1.75亿美元的普通股公开发行。该公司表示,此次发行所得净资金将用于企业一般运营需求,包括临床试验推进及研发项目投入。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.